Patent ID: 7816522
Filing Date: 2010-10-19
Classification: A61P,C07D

Abstract:
1. A compound selected from the group consisting of 4-({[2-fluoro-3-(2-hydroxyethoxy)-5-methoxyphenyl]-(5-oxo-1-pyrimidin-2-yl-4,5-dihydro-1H-[1,2,4]triazol-3-yl)methyl}amino)benzamidine: 4-{3-[(4-carbamimidoylphenylamino)-(8-methoxy-4H-benzo[1,3]dioxin-6-yl)methyl]-5-oxo-4,5-dihydro-[1,2,4]triazol-1-yl}thiazole-5-carboxylic acid: 4-(3-{(4-carbamimidoylphenylamino)-[2-fluoro-3-(2-hydroxyethoxy)-5-methoxyphenyl]methy}-5-oxo-4,5-dihydro[1,2,4]triazol-1-yl)thiazole-5-carboxylic acid: or pharmaceutically acceptable salts thereof.